Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: Differential inhibition of synaptosomal and vesicular [3H]dopamine uptake

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 3, 1997, Pages 1432-1444

  Teng, Lihong ^a   Crooks, Peter A ^a   Sonsalla, Patricia K ^b   Dwoskin, Linda P ^a  

^a University of Kentucky   (United States)

^b University of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NOMIFENSINE; PARGYLINE; TRITIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; SYNAPSE VESICLE; SYNAPTOSOME;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CALCIUM; CORPUS STRIATUM; DOPAMINE; LOBELINE; MALE; MECAMYLAMINE; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC VESICLES; SYNAPTOSOMES; TRITIUM;

EID: 0030904958     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. 3H]methylcarbamylcholine in rat brain. Eur. J. Pharmacol. 253: 261-267, 1994.
2. BANERJEE, S. AND ABOOD, L. G.: Nicotine antagonists: Phosphoinositide turnover and receptor binding to determine muscarinic properties. Med. Pharmacol. 38(17): 2933-2935, 1989.
3. BARLOW, R. B. AND JOHNSON, O.: Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)cytisine and (-)lobeline hydrochloride and a comparison with (-)nicotine and other nicotine-like compounds. Br. J. Pharmacol. 98: 799-808, 1989.
4. BEERS, M. F., JOHNSON, R. G. AND SCARPA, A.: Evidence for an ascorbate shuttle for the transfer of reducing equivalents across chromaffin granule membranes. J. Biol. Chem. 261(6): 2529-2535, 1986.
5. BENOWITZ, N. L., PORCHET, H. AND JACOB III, P.: Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In Nicotine Psychopharmacology: Molecular, Cellular, and Behavioral Aspects. ed by S. Wonnacott, M. A. H. Russel and I. P. Stolerman, pp. 112-157, Oxford University Press, New York, New York, 1990.
6. BENWELL, M. E. M. AND BALFOUR, D. J. K.: The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol. 105: 849-856, 1992.
7. 3H]nicotine binding sites in human brain. J. Neurochem. 50(4): 1243-1247, 1988.
8. BHAT, R. V., MARKS, M. J. AND COLLINS, A. C.: Effects of chronic nicotine infusion on kinetics of high-affinity nicotine binding. J. Neurochem. 62(2): 574-581, 1994.
9. BHAT, R. V., TURNER, S. L., SELVAAG, S. R., MARKS, M. J. AND COLLINS, A. C.: Regulation of brain nicotinic receptors by chronic agonist infusion. J. Neurochem. 56(6): 1932-1939, 1991.
10. BRAZELL, M. P., MITCHELL, S. N., JOSEPH, M. H. AND GRAY, J. A.: Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with the caudate-putamen. Neuropharmacology 29(12): 1177-1185, 1990.
11. BRIONI, J. D., O'NEILL, A. B., KIM, D. J. B. AND DECKER, M. W.: Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 238: 1-8, 1993.
12. BROWNSTEIN, M. J. AND HOFFMAN, B. J.: Neurotransmitter transporters. Rec. Prog. Hormone Res. 49: 27-42, 1994.
13. 3H-nicotine in the mouse brain. Life Sci. 44: 1123-1132, 1989.
14. CHESSELET, M. F.: Presynaptic regulation of neurotransmitter release in the brain: Facts and hypotheses. Neuroscience 12(2): 347-375, 1984.
15. CLARKE, P. B. S.: Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem. Pharmacol. 40(7): 1427-1432, 1990.
16. CLARKE, P. B. S. AND FIBIGER, H. C.: Apparent absence of nicotine-induced conditioned place preference in rats. Psychopharmacology 92(1): 84-88, 1987.
17. CLARKE, P. B. S. AND KUMAR, R.: The effect of nicotine on locomotor activity in non-tolerant and tolerant rats. Br. J. Pharmacol. 78(2): 329-337, 1983a.
18. CLARKE, P. B. S. AND KUMAR, R.: Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br. J. Pharmacol. 80(3): 587-594, 1983b.
19. CLARKE, P. S. AND PERT, A.: Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348: 355-358, 1985.
20. COLLINS, A. C., ROMM, E. AND WEHNER, J. M.: Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors. Brain Res. Bull. 25(3): 373-379, 1990.
21. CORRIGAL, W. A., FRANKLIN, K. B. J., COEN, K. M. AND CLARKE, P. B. S.: The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107: 285-289, 1992.
22. CORRIGAL, W. A., COEN, K. M. AND ADAMSON, K. L.: Self-administrated nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653: 278-284, 1994.
23. 3H]dihydroxyphenylacetic acid. J. Pharmacol. Exp. Ther. 209(2): 165-175, 1979.
24. DAMSMA, G., DAY, J. AND FIBIGER, H. C.: Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 168(3): 363-368, 1989.
25. 3H]dopamine. Life Sci. 42: 2553-2559, 1988.
26. DECKER, M. W., BRIONI, J. D., BANNON, A. W. AND ARNERIC, S. P.: Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics. Life Sci. 56(8): 545-570, 1995.
27. DECKER, M. W., MAJCHZARK, M. J., AND ARNERIC, S. P.: Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45: 571-576, 1993.
28. DONNY, E. C., CAGGIULA, A. R., KNOF, S. AND BROWN, C.: Nicotine self-administration in rats. Psychopharmacol. 122: 390-394, 1995.
29. DORSEY, J. L.: Control of the tobacco habit. Ann. Int. Med. 10: 628-631, 1936.
30. 3H]nomifensine to striatal membranes. Biochem. Pharmacol. 34(8): 1137-1144, 1985.
31. DWOSKIN, L. P., GERHARDT, G. A., DREBING, C. J., WILCOX, C. C. AND ZAHNISER, N. R.: Uptake and release of dopamine from rat striatal slices: Comparison of PCP, amphetamine and nomifensine. In Pharmacology and Functional Regulation of Dopamine Neurons, ed by P. M. Beart, G. N., Woodruff and D. M. Jackson, pp. 248-250, Macmillan Press, Basingstoke, 1988.
32. 3H]dopamine release from rat striatal slices by D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 239: 442-453, 1986.
33. 3H]dopamine accumulation by synaptic vesicles purified from rat striatum: Inhibition by thiocyanate ion. Brain Res. 516: 155-160, 1990.
34. FISCHER, J. F. AND CHO, A. K.: Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208(2): 203-209, 1979.
35. FUDALA, P. J. AND IWAMOTO, E. T.: Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol. Biochem. Behav. 25: 1041-1049, 1986.
36. FUDALA, P. J., TEOH, K. W. AND IWAMOTO, E. T.: Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol. Biochem. Behav. 22(2): 237-241, 1985.
37. FUNG, Y. K. AND LAU, Y. S.: Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine treated rats. Eur. J. Pharmacol. 152(3): 263-271, 1988.
38. GELLER, I., HARTMAN, R. AND BLUM, K.: Effects of nicotine, nicotine monomethiodide, lobeline, chlordiazepoxide, meprobamate and caffeine on a discrimination task in laboratory rats. Psychopharmacologia (Berl.). 20: 355-365, 1971.
39. GERHARDT, G. A., DWOSKIN, L. P. AND ZAHNISER, N. R.: Outflow and overflow of picogram levels of endogenous dopamine and DOPAC from rat striatal slices: Improved methods for studies of stimulus-evoked release and metabolism. J. Neurosci. Meth. 26: 217-227, 1989.
40. GIORGUIEFF-CHESSELET, M. F., KEMEL, M. L., WANDSCHEER, D. AND GLOWINSKI, J.: Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: Effect of nicotine in a low concentration. Life Sci. 25: 1257-1262, 1979.
41. GONZALEZ, A. M., WALTHER, D., PAZOS, A. AND UHL, G. R.: Synaptic vesicular monoamine transporter expression: Distribution and pharmacologic profile. Mol. Brain Res. 22: 219-226, 1994.
42. 3H-dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59: 848-856, 1992.
43. 3H]dopamine release from mouse striatal synaptosomes. J. Neurochem. 62(4): 1390-1398, 1994.
44. GRAHAM, D. G., TIFFANY, S. M., BELL, W. R. AND GUTKNECHT, W. F.: Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds towards C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14: 644-653, 1978.
45. HAMANN, S. R. AND MARTIN, W. R.: Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)lobeline in the rat brainstem. Pharmacol. Biochem. Behav. 47: 197-201, 1994.
46. HARSING, L. G., SERSHEN, H. AND LAJTHA, A.: Dopamine efflux from striatum after chronic nicotine: Evidence for autoreceptor desensitization. J. Neurochem. 59: 48-54, 1992.
47. HART, C. AND KSIR, C.: Nicotine effects on dopamine clearance in rat nucleus accumbens. J. Neurochem. 66(1): 216-221, 1996.
48. 2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur. J. Pharmacol. 166: 261-269, 1989.
49. IMPERATO, A., MULAS, A. AND CHIARA, G. D.: Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharm. 132: 337-338, 1986.
50. 3H]dopamine release in rat striatum. J. Neurochem. 56(2): 603-610, 1991.
51. JOHNSON, R. G., JR.: Accumulation of biological amines into chromaffin granules: A model for hormone and neurotransmitter transport. Physiol. Rev. 68: 232-307, 1988.
52. KALYUZHNYY, V. V.: The treatment of nicotinism with the aid of lobeline and its influence on vegetative and vascular reactions. J. Neural. Psychiat. 68: 1864-1870, 1968.
53. KNEPPER, S. M., GRUNEWALD, G. L. AND RUTLEDGE, C. O.: Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs. J. Pharmacol. Exp. Ther. 247(2): 487-494, 1988.
54. KRAMER, H. K., SERSHEN, H., LAJTHA, A. AND REITH, M. E. A.: The effect of nicotine on catecholaminergic storage vesicles. Brain Res. 503: 296-298, 1989.
55. LEVI, G. AND RAITERI, M.: Carrier-mediated release of neurotransmitters. TINS. 16(10): 415-419, 1993.
56. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabeled dopamine. Biochem. Physiol. 31(6): 983-992, 1982.
57. 3H]nicotine to a single class of high affinity sites in rat brain membrane. Mol. Pharmacol. 29: 448-454, 1986.
58. 3H](-)-nicotine binding in rat cortex. Neuropharmacology 32(9): 847-853, 1993.
59. MANTLE, T. J., TIPTON, K. F. AND GARRETT, N. J.: Inhibition of monamine oxidase by amphetamine and related compounds. Biochem. Pharmacol. 25: 2073-2077, 1976.
60. MARKS, M. J., PAULY, J. R., GROSS, S. D., DENERIS, E. S., HERMANS-BORGMEYER, I., HEINEMANN, S. F. AND COLLINS, A. C.: Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12(7): 2765-2784, 1992.
61. 3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats. J. Pharmacol. Exp. Ther. 270(1): 133-141, 1994.
62. MILLER, H. H., SHORE, P. A. AND CLARKE. D. E.: In vivo monoamine oxidase inhibition by d-amphetamine. Biochem. Pharmacol. 29: 1347-1354, 1980.
63. NUNN-THOMPSON, C. L. AND SIMON, P. A.: Pharmacotherapy for smoking cessation. Clin. Pharmacol. 8: 710-720, 1989.
64. OLIN, B. R., HEBEL, S. K., GREMP, J. L. AND HULBERTT, M. K.: Smoking deterrents. In Drug Facts and Comparisons, 1995 edition, ed. by B. R. Olin, S. K. Hebel, J. L. Gremp, and M. K. Hulbertt. pp. 3087-3095, J. B. Lippincott Co., St. Louis, 1995.
65. PARKER, E. M. AND CUBEDDU, L. X.: Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. J. Pharmacol. Exp. Ther. 237(1): 179-192, 1986a.
66. PARKER, E. M. AND CUBEDDU, L. X.: Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. J. Pharmacol. Exp. Ther. 237(1): 193-203, 1986b.
67. PENG, X., GERZANICH, V., ANAND, R., WHITING, P. J. AND LINDSTROM, J.: Nicotine-induced increase in the neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46: 523-530, 1994.
68. PRIGNOT, J.: Pharmacological approach to smoking cessation. Eur. Respir. J. 2: 550-560, 1989.
69. RAPIER, C., LUNT, G. G. AND WONNACOTT, S.: Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: Concentration dependence and repetitive stimulation. J. Neurochem. 50(4): 1123-1130, 1988.
70. 3H]dopamine release from striatal synaptosomes: Pharmacological characterization. J. Neurochem. 54(3): 937-945, 1990.
71. 3H](-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacol. 27(3): 235-241, 1988.
72. REAVILL, C., WALTHER, B., STOLERMAN, I. P. AND TESTA, B.: Behavioral and pharmacokinetics studies on nicotine, cytosine and lobeline. Neuropharmacology 29(7): 619-624, 1990.
73. ROMANO, C. AND GOLDSTEIN, A.: Stereospecific nicotine receptors on rat brain membranes. Science (Wash. DC) 210: 647-649, 1980.
74. 3H]nicotine eliminates low affinity binding. Life Sci. 46: 935-943, 1990.
75. ROSS, S. B. AND RENYI, A. L.: Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro. Acta Pharmacologica 24: 297-309, 1966.
76. 3H]dopamine from rat striatal synaptosomes. Neurosci. Lett. 189(3): 171-175, 1995.
77. 3H]dopamine release by nicotine in rat nucleus accumbens. J. Neurochem. 49(5): 1149-1154, 1987.
78. ROWELL, P. P. AND HILL, A. S.: Apparent inability of nicotine to inhibit dopamine uptake into rat striatal tissue in vitro. The Pharmacologist. 35: 134, 1993.
79. ROWELL, P. P. AND HILLEBRAND, J. A.: Desensitization of nicotine-stimulated dopamine release from rat striatal synaptosomes. The Pharmacologist 34: 154, 1992.
80. ROWELL, P. P. AND HILLEBRAND, J. A.: Characterization of nicotine-induced desensitization of evoked dopamine release from rat striatal synaptosomes. J. Neurochem. 63: 561-569, 1994.
81. 3H]metabolites in rat striatum by nicotinic drugs. Brain Res. 242: 99-106, 1982.
82. SANDERSON, E. M., DRASDO, A. L., MCCREA, K. AND WONNACOTT, S.: Upregulation of nicotinic receptors following continuous infusion of nicotine is brainregion-specific. Brain Res. 617(2): 349-352, 1993.
83. SACAAN, A. I., DUNLOP, J. L. AND LLOYD, G. K.: Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274(1): 224-230, 1995.
84. SCHECHTER, M. D. AND ROSECRANS, J. A.: Nicotine as a discriminative cue in rats: Inability of related drugs to produce a nicotine-like cuing effect. Psychopharmacologia (Berl.). 27: 379-387, 1972.
85. SCHULDINER, S., STEINER-MORDOCH, S., YELIN, R., WALL, S. C. AND RUDNICK, G.: Amphetamine derivatives interact with both plasma membrane and secretary vesicle biogenic amine transporter. Mol. Pharmacol. 44(6): 1227-1231, 1993.
86. SEGAL, D. S. AND KUCZENSKI, R.: Individual differences in responsiveness to single and repeated amphetamine administration: Behavioral characteristics and neurochemical correlates. J. Pharmacol. Exp. Ther. 242: 917-926, 1987.
87. SHOAIB, M., STOLERMAN, I. P. AND KUMAR, R. C.: Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology 113: 445-452, 1994.
88. SLIVKA, A. AND COHEN, G.: Hydroxyl radical attack on dopamine. J. Biol. Chem. 260: 15446-15472, 1985.
89. SLOAN, J. W., MARTIN, W. R., BOSTWICK, M., HOOK, R. AND WALA, E.: The competitive binding characteristics of nicotinic ligands and their pharmacology. Pharmacol. Biochem. Behav. 30: 255-267, 1988.
90. STOLERMAN, I. P., GARCIA, H. S. AND MIRZA, N. R.: Dissociation between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology 117: 530-437, 1995.
91. SULZER, D. AND RAYPORT, S.: Amphetamine and other psychostimulants reduce pH gradient in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action. Neuron 5: 797-808, 1990.
92. SULZER, D., CHEN, T. K., LAU, Y. Y., KRISTENSEN, H., RAYPORT, S. AND EWING, A.: Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15(5): 4102-4108, 1995.
93. + stimulation, methamphetamine and nicotinic drugs. Brain Res. 279: 330-334, 1983.
94. TOTH, E., SERSHEN, H., HASHIM, A., VIZI, E. S. AND LAJTHA, A.: Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: Role of glutamic acid. Neurochem. Res. 17(3): 265-271, 1992.
95. VARANDA, W. A., ARACAVA, Y., SHERBY, S. M., VAN METER, W. G., ELDEFRAWI, M. E. AND ALBUQUERQUE, E. X.: The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Mol. Pharmacol. 28(2): 128-137, 1985.
96. 14C]dopamine from rat brain slices. Neuropharmacology 13(8): 693-700, 1974.
97. WESTFALL, T. C., PERRY, H. AND VICKERY, L.: Mechanisms of nicotine regulation of dopamine release in neostriatum. In Tobacco Smoking and Nicotine, ed. by W. R. Martin, G. R. VanLoon, E T. Iwamoto and L. Davis, pp. 209-223, Plenum, New York, 1987.
98. WRIGHT, I. S. AND LITTAUER, D.: Lobeline sulfate: Its pharmacology and use in the treatment of the tobacco habit. JAMA. 109: 649-654, 1937.
99. YAMADA, S., ISOGAI, M., KAGAWA, Y., TAKAYANAGI, N., HAYAKHI, E., TSUJI, K. AND KOSUGE, T.: Brain nicotinic acetylcholine receptors: biochemical characterization by neosurugatoxin. Mol. Pharmacol. 28: 120-127, 1985.
100. YAMASHITA, H., KITAYAMA, S., ZHANG, Y. X., TAKAHASHI, T., DOHI, T. AND NAKAMURA, S.: Effect of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC12 cells. Biochem. Pharmacol. 49(5): 742-745, 1995.
101. 3H]amphetamine with rat brain synaptosomes. II. Active transport. J. Pharmacol. Exp. Ther. 257: 830-835, 1991.
102. ZUMSTEIN, K , KARDUCK, W. AND STARKE, K.: Pathways of dopamine metabolism in rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 316: 205-217, 1981.